Question follow-through · 7126

Prescriptions: Fees and Charges

To ask the Secretary of State for Health and Social Care, if he will commit to a review of the prescription charge exemption list to reflect the changing nature of many long-term conditions including cystic fibrosis.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
5 Jun 2026
Target answer date
9 Jun 2026
Answer
15 Jun 2026 · 10 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 5 Jun 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, if he will commit to a review of the prescription charge exemption list to reflect the changing nature of many long-term conditions including cystic fibrosis.

  2. 9 Jun 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 15 Jun 2026

    Answer published

    The Government currently has no plans to review or amend the list of medical conditions that entitle someone to apply for a medical exemption certificate.

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Gynaecology

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of consultant obstetricians and gynaecologists to support delivery of the 2026 Renewed Women’s Health Strategy for England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Gynaecology: Waiting Lists

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 2026 Renewed Women’s Health Strategy for England on waiting times for gynaecology services.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Women's Health Hubs

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of women’s health hubs on delivering the objectives of the 2026 Renewed Women’s Health Strategy for England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Gynaecology: Disadvantaged

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to specialist women’s health services for women in deprived areas.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Gynaecology

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to publish annual progress reports on the implementation of the 2026 Renewed Women’s Health Strategy for England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Diethylstilbestrol: Medical Records

25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that individuals known to have been exposed to diethylstilbestrol (DES) in utero have that exposure recorded on their own NHS medical records, rather t

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Diethylstilbestrol: Side Effects

25 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to issue guidance to NHS England on the provision of additional cervical and vaginal cancer surveillance for women exposed in utero to diethylstilbestrol (DES), beyond HPV primary

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Diethylstilbestrol: Health Education

25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that Government policy and NHS guidance relating to diethylstilbestrol (DES) exposure are communicated to and accessible by all people exposed to DES i

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Neurology: Drugs

29 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether the Care Quality Commission's assessment framework requires providers to evidence medicines safety checks for psychiatric history, psychotropic medication use and previous psychiatric adver

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Neurology: Drugs

29 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether NHS England's neurology service specifications require providers to include structured mental health and medication safety fields in headache referral, assessment and prescribing templates.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Migraines: Drugs

29 Jun 2026 · To ask the Secretary of State for Health and Social Care, what mechanism exists for psychiatric adverse drug reaction signals, including Yellow Card reports and Prevention of Future Deaths reports, to be considered in national migraine prescribing guidanc

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Psychotherapy: Regulation

6 Jul 2026 · To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the potential impact of psychotherapy and counselling remaining outside statutory regulation on public protection, in the context that other psychological